428 related articles for article (PubMed ID: 8574734)
81. High effectiveness and safety of one-week antibiotic regimen in Helicobacter pylori eradication.
Dalla Libera M; Pazzi P; Carli G; Gamberini S; Scagliarini R; Merighi A; Gullini S
Aliment Pharmacol Ther; 1996 Apr; 10(2):203-6. PubMed ID: 8730251
[TBL] [Abstract][Full Text] [Related]
82. [Azithromycin-omeprazole. Treatment for the eradication of Helicobacter pylori].
Marchi M; Vacondio R; Bagnulo A; Mengoli M
Minerva Gastroenterol Dietol; 1994 Mar; 40(1):47-9. PubMed ID: 8204705
[TBL] [Abstract][Full Text] [Related]
83. [Prevalence and treatment of Helicobacter pylori in gastro-duodenal ulcers. An experience in Liege].
Lutgen N; Delforge M; Bastens B; Demoulin JC; Fontaine F; Gillard V; Gerard A
Rev Med Liege; 2001 Jan; 56(1):25-30. PubMed ID: 11256133
[TBL] [Abstract][Full Text] [Related]
84. Colloidal bismuth subcitrate in non-ulcer dyspepsia.
Khanna MU; Abraham P; Nair NG; Mistry FP; Vora IM
J Postgrad Med; 1992; 38(3):106-8. PubMed ID: 1303406
[TBL] [Abstract][Full Text] [Related]
85. Comparison of the efficacy and safety of different formulations of omeprazole-based triple therapies in the treatment of Helicobacter pylori-positive peptic ulcer.
Kim HS; Lee DK; Kim KH; Jeong YS; Kim JW; Seo JI; Baik SK; Kwon SO; Cho MY
J Gastroenterol; 2001 Feb; 36(2):96-102. PubMed ID: 11227677
[TBL] [Abstract][Full Text] [Related]
86. Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment.
van der Hulst RW; Weel JF; Verheul SB; Keller JJ; ten Kate FJ; van der Ende A; Rauws EA; Dankert J; Tytgat GN
Aliment Pharmacol Ther; 1996 Apr; 10(2):165-71. PubMed ID: 8730245
[TBL] [Abstract][Full Text] [Related]
87. [Role of anti-secretory treatment in addition to Helicobacter pylori eradication triple therapy in the treatment of peptic ulcer].
Jung JM; Shim KN; Oh HJ; Na YJ; Jung HS; Jung SA; Yoo K
Korean J Gastroenterol; 2008 Jan; 51(1):11-8. PubMed ID: 18349557
[TBL] [Abstract][Full Text] [Related]
88. Treating Helicobacter pylori.
Howden CW; Hunt RH
Arch Intern Med; 1998 Nov; 158(21):2396-8. PubMed ID: 9827792
[No Abstract] [Full Text] [Related]
89. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection.
Dore MP; Piana A; Carta M; Atzei A; Are BM; Mura I; Massarelli G; Maida A; Sepulveda AR; Graham DY; Realdi G
Aliment Pharmacol Ther; 1998 Jul; 12(7):635-9. PubMed ID: 9701526
[TBL] [Abstract][Full Text] [Related]
90. Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Adamsson I; Nord CE; Lundquist P; Sjöstedt S; Edlund C
J Antimicrob Chemother; 1999 Nov; 44(5):629-40. PubMed ID: 10552979
[TBL] [Abstract][Full Text] [Related]
91. Low dose, short-term, triple therapy for helicobacter pylori associated peptic ulcer.
Zuberi BF; Lal S; Sheikh RM
J Pak Med Assoc; 1997 Sep; 47(9):228-30. PubMed ID: 9361485
[TBL] [Abstract][Full Text] [Related]
92. No additional value of bismuth subcitrate to combination omeprazole/amoxicillin therapy in the eradication of Helicobacter pylori.
Tan AC; den Hartog G; Meijer JW; Thies JE; de Vries RA; Mulder CJ
Helicobacter; 1997 Dec; 2(4):194-8. PubMed ID: 9421123
[TBL] [Abstract][Full Text] [Related]
93. [Omeprazole and amoxycillin in the eradicating treatment of Helicobacter pylori].
Gisbert JP; Boixeda D; Martin de Argila C
Rev Clin Esp; 1995 Nov; 195(11):787-91. PubMed ID: 8560037
[No Abstract] [Full Text] [Related]
94. Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial.
Vaira D; Zullo A; Vakil N; Gatta L; Ricci C; Perna F; Hassan C; Bernabucci V; Tampieri A; Morini S
Ann Intern Med; 2007 Apr; 146(8):556-63. PubMed ID: 17438314
[TBL] [Abstract][Full Text] [Related]
95. Helicobacter pylori and nonulcer dyspepsia.
Friedman LS
N Engl J Med; 1998 Dec; 339(26):1928-30. PubMed ID: 9862951
[No Abstract] [Full Text] [Related]
96. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
[TBL] [Abstract][Full Text] [Related]
97. Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Färkkilä M; Sarna S; Valtonen V; Sipponen P;
Scand J Gastroenterol; 2004 Apr; 39(4):327-35. PubMed ID: 15125464
[TBL] [Abstract][Full Text] [Related]
98. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
[TBL] [Abstract][Full Text] [Related]
99. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Spiller RC
Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S25-8; discussion S43-5. PubMed ID: 10503819
[TBL] [Abstract][Full Text] [Related]
100. H. pylori and nonulcer dyspepsia: not guilty as charged.
Schubert ML
Gastroenterology; 1999 Jul; 117(1):270-2. PubMed ID: 10381939
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
